News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,140 Results
Type
Article (14926)
Company Profile (299)
Press Release (266909)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79979)
Career Advice (162)
Deals (13364)
Drug Delivery (39)
Drug Development (50807)
Employer Resources (31)
FDA (5845)
Job Trends (5179)
News (145341)
Policy (10089)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (922)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21795)
ALS (125)
Alzheimer's disease (1033)
Antibody-drug conjugate (ADC) (241)
Approvals (6040)
Artificial intelligence (259)
Autoimmune disease (114)
Automation (10)
Bankruptcy (105)
Best Places to Work (4572)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3140)
Cardiovascular disease (237)
Career advice (147)
Career pathing (7)
CAR-T (219)
CDC (5)
Cell therapy (573)
Cervical cancer (14)
Clinical research (43749)
Collaboration (1155)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1105)
CRISPR (86)
C-suite (553)
Cystic fibrosis (112)
Data (4331)
Denatured (15)
Depression (92)
Diabetes (258)
Diagnostics (1380)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (215)
Earnings (31742)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51781)
Executive appointments (624)
FDA (7601)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (982)
Gene editing (183)
Generative AI (21)
Gene therapy (489)
GLP-1 (504)
Government (1148)
Grass and pollen (3)
Guidances (166)
Healthcare (6633)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (191)
Immuno-oncology (41)
Indications (67)
Infectious disease (1210)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7367)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1403)
Liver cancer (42)
Longevity (11)
Lung cancer (420)
Lymphoma (250)
Machine learning (24)
Management (7)
Manufacturing (381)
MASH (130)
Medical device (2662)
Medtech (2671)
Mergers & acquisitions (6621)
Metabolic disorders (728)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (231)
Neuropsychiatric disorders (70)
Neuroscience (1955)
Neurotech (1)
NextGen: Class of 2026 (2035)
Non-profit (866)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (233)
Partnered (12)
Patents (302)
Patient recruitment (329)
Peanut (43)
People (26669)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15516)
Phase 2 (20328)
Phase 3 (12841)
Pipeline (3267)
Policy (90)
Postmarket research (853)
Preclinical (6551)
Press Release (32)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (651)
Real estate (1451)
Recruiting (12)
Regulatory (9914)
Reports (19)
Research institute (973)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (335)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (47)
Last 7 days (340)
Last 30 days (1162)
Last 365 days (17869)
2026 (1699)
2025 (18127)
2024 (20589)
2023 (22448)
2022 (26871)
2021 (27873)
2020 (23426)
2019 (16270)
2018 (11762)
2017 (13793)
2016 (11887)
2015 (14372)
2014 (10412)
2013 (7490)
2012 (7538)
2011 (7616)
2010 (7429)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18282)
Australia (3112)
California (7088)
Canada (1839)
China (775)
Colorado (247)
Connecticut (252)
Delaware (235)
Europe (39286)
Florida (903)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (161)
Iowa (8)
Japan (223)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5591)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1652)
New Mexico (13)
New York (1766)
North Carolina (828)
North Dakota (6)
Northern California (3485)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1279)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2809)
Tennessee (40)
Texas (909)
United States (23386)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (607)
West Virginia (1)
Wisconsin (45)
282,140 Results for "tcr2 therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Lion TCR’s Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
February 12, 2025
·
5 min read
Drug Development
Replay’s cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myeloma
Replay’s cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myeloma
March 11, 2024
·
5 min read
Press Releases
TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
November 5, 2025
·
1 min read
Drug Development
TCR2 Therapeutics’ Gavo-Cel Shows Early Promise in Solid Tumors, Ovarian Cancer
TCR2 Therapeutics announced promising Phase I data for gavo-cel in mesothelin-expression that points toward effects in multiple solid tumors, especially ovarian cancer.
September 28, 2022
·
3 min read
·
Mark Terry
Genetown
TCR2 Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 01, 2022
Therapeutics Inc. announced the Compensation Committee of the Board of Directors of TCR2 approved the grant of inducement stock options covering an aggregate of 7,600 shares of TCR2’s common stock to 2 new non-executive employees.
September 1, 2022
·
2 min read
Press Releases
TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
·
12 min read
Drug Development
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting
Alaunos Therapeutics, Inc. announced that the Company will present early translational data from the first three patients treated in its ongoing TCR-T Library Phase 1/2 trial at the 2023 American Society of Clinical Oncology Annual Meeting taking place June 2-6, 2023, at the McCormick Place Convention Center in Chicago.
May 25, 2023
·
7 min read
Press Releases
Aclaris Therapeutics’ Novel ITK/JAK3 Inhibitor ATI-2138 Demonstrates Rapid and Sustained Hair Regrowth in Validated Murine Model of Alopecia Areata (AA)
January 27, 2026
·
6 min read
Press Releases
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
January 26, 2026
·
4 min read
1 of 28,214
Next
